On the Integration of In Silico Drug Design Methods for Drug Repurposing

被引：133

作者：

March-Vila, Eric ^{[1
]}

Pinzi, Luca ^{[1
]}

Sturm, Noe ^{[1
]}

Tinivella, Annachiara ^{[1
]}

Engkvist, Ola ^{[2
]}

Chen, Hongming ^{[2
]}

Rastelli, Giulio ^{[1
]}

机构：

[1] Univ Modena & Reggio Emilia, Dept Life Sci, Mol Modelling & Drug Design Lab, Modena, Italy

[2] AstraZeneca R&D Gothenburg, Discovery Sci Innovat Med & Early Dev Biotech Uni, Molndal, Sweden

来源：

FRONTIERS IN PHARMACOLOGY | 2017年 / 8卷

关键词：

drug repurposing; drug discovery; molecular modeling; chemogenomics; structure-based drug design; ligand-based drug design; machine learning; transcriptomics; LIGAND-BASED APPROACH; GENE-EXPRESSION; BINDING-SITES; PREDICTION; DISCOVERY; PHARMACOLOGY; POLYPHARMACOLOGY; IDENTIFICATION; INTERACTOME; INHIBITORS;

D O I：

10.3389/fphar.2017.00298

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Drug repurposing has become an important branch of drug discovery. Several computational approaches that help to uncover new repurposing opportunities and aid the discovery process have been put forward, or adapted from previous applications. A number of successful examples are now available. Overall, future developments will greatly benefit from integration of different methods, approaches and disciplines. Steps forward in this direction are expected to help to clarify, and therefore to rationally predict, new drug-target, target-disease, and ultimately drug-disease associations.

引用

页数：7

共 50 条

[31] Computational insights into pediatric adenovirus inhibitors: in silico strategies for drug repurposing
Sarkar, Kaushik
Nandi, Subrata
Das, Rajesh Kumar
[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,
[32] In Silico Drug Design and Medicinal Chemistry
Singla, Rajeev K.
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (11) : 971 - 972
[33] Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches
Alizadeh, Ali Akbar
Jafari, Behzad
Dastmalchi, Siavoush
[J]. ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (01) : 113 - 122
[34] Bioinformatics methods in drug repurposing for Alzheimer's disease
Siavelis, John C.
Bourdakou, Marilena M.
Athanasiadis, Emmanouil I.
Spyrou, George M.
Nikita, Konstantina S.
[J]. BRIEFINGS IN BIOINFORMATICS, 2016, 17 (02) : 322 - 335
[35] Deep learning for drug repurposing: Methods, databases, and applications
Pan, Xiaoqin
Lin, Xuan
Cao, Dongsheng
Zeng, Xiangxiang
Yu, Philip S.
He, Lifang
Nussinov, Ruth
Cheng, Feixiong
[J]. WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2022, 12 (04)
[36] Computational Approaches to Drug Repurposing: Methods, Challenges, and Opportunities
Cousins, Henry C.
Nayar, Gowri
Altman, Russ B.
[J]. ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, 2024, 7 : 15 - 29
[37] Drug Repurposing for Drug Development in Stroke
Fagan, Susan C.
[J]. PHARMACOTHERAPY, 2010, 30 (07): : 51S - 54S
[38] Drug databases and their contributions to drug repurposing
Masoudi-Sobhanzadeh, Yosef
Omidi, Yadollah
Amanlou, Massoud
Masoudi-Nejad, Ali
[J]. GENOMICS, 2020, 112 (02) : 1087 - 1095
[39] Drug Design of GLP-1 Receptor Agonists: Importance of In Silico Methods
Sharma, Smriti
Bhatia, Vinayak
[J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (08) : 1015 - 1024
[40] Drug Repurposing Based on Drug-Drug Interaction
Zhou, Bin
Wang, Rong
Wu, Ping
Kong, De-Xin
[J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (02) : 137 - 144

← 1 2 3 4 5 →